PL2614090T3 - Hybrydowe kompleksy kooperatywne kwasu hialuronowego - Google Patents

Hybrydowe kompleksy kooperatywne kwasu hialuronowego

Info

Publication number
PL2614090T3
PL2614090T3 PL11769800T PL11769800T PL2614090T3 PL 2614090 T3 PL2614090 T3 PL 2614090T3 PL 11769800 T PL11769800 T PL 11769800T PL 11769800 T PL11769800 T PL 11769800T PL 2614090 T3 PL2614090 T3 PL 2614090T3
Authority
PL
Poland
Prior art keywords
hyaluronic acid
hybrid cooperative
cooperative complexes
complexes
hybrid
Prior art date
Application number
PL11769800T
Other languages
English (en)
Other versions
PL2614090T5 (pl
Inventor
Rosa Mario De
Antonella D'agostino
Gatta Annalisa La
Chiara Schiraldi
Original Assignee
Altergon S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43528358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2614090(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altergon S.A. filed Critical Altergon S.A.
Publication of PL2614090T3 publication Critical patent/PL2614090T3/pl
Publication of PL2614090T5 publication Critical patent/PL2614090T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16—Cyclodextrin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
PL11769800.1T 2010-09-09 2011-09-09 Hybrydowe kompleksy kooperatywne kwasu hialuronowego PL2614090T5 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A001635A IT1402382B1 (it) 2010-09-09 2010-09-09 Complessi cooperativi ibridi di acido ialuronico
PCT/EP2011/065633 WO2012032151A2 (en) 2010-09-09 2011-09-09 Hybrid cooperative complexes of hyaluronic acid

Publications (2)

Publication Number Publication Date
PL2614090T3 true PL2614090T3 (pl) 2017-03-31
PL2614090T5 PL2614090T5 (pl) 2024-07-29

Family

ID=43528358

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11769800.1T PL2614090T5 (pl) 2010-09-09 2011-09-09 Hybrydowe kompleksy kooperatywne kwasu hialuronowego

Country Status (12)

Country Link
US (2) US20130165404A1 (pl)
EP (1) EP2614090B2 (pl)
CA (1) CA2810742C (pl)
DK (1) DK2614090T4 (pl)
ES (1) ES2613067T3 (pl)
FI (1) FI2614090T4 (pl)
HU (1) HUE031242T2 (pl)
IT (1) IT1402382B1 (pl)
LT (1) LT2614090T (pl)
PL (1) PL2614090T5 (pl)
PT (1) PT2614090T (pl)
WO (1) WO2012032151A2 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2596796T3 (da) * 2011-11-24 2014-01-27 Quimera Ingenieria Biomedica S L Kompleks opnået af hyaluronsyre eller et salt deraf samt chondroitinsulfatblandinger
ITMI20120896A1 (it) 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
CN104592702B (zh) * 2014-12-26 2017-05-31 四川大学 可自愈合的有机物/无机纳米粒子杂化材料及其制备方法
ITUB20152542A1 (it) 2015-07-28 2017-01-28 Altergon Sa Formulati oftalmici a base di complessi cooperativi di acido ialuronico a basso e alto peso molecolare
CN107802597B (zh) * 2017-12-08 2020-07-31 北京诺康达医药科技股份有限公司 一种玻璃酸钠组合物及其制备方法和应用
IT201900006250A1 (it) 2019-04-23 2020-10-23 Fidia Farm Spa Medicazione per il trattamento della cute lesa
IT201800010415A1 (it) * 2018-11-19 2020-05-19 Innate S R L Composizione iniettabile comprendente acido ialuronico e trealosio e uso della detta composizione.
IT201900021693A1 (it) 2019-11-20 2021-05-20 Bmg Pharma S P A Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione
IT201900024208A1 (it) * 2019-12-17 2021-06-17 Altergon Sa Miscele iniettabili di acido ialuronico per uso in dermoestetica
IT201900024214A1 (it) 2019-12-17 2021-06-17 Altergon Sa Sostituti del liquido sinoviale
IT202000002866A1 (it) 2020-02-13 2021-08-13 Altergon Sa Composizioni antivirali
CN113244384A (zh) 2020-02-11 2021-08-13 阿尔特刚股份有限公司 抗病毒组合物
IT202000002641A1 (it) 2020-02-11 2021-08-11 Altergon Sa Composizioni antivirali
IT202000029288A1 (it) 2020-12-01 2022-06-01 Altergon Sa Sali di microbiocidi biguanidinici con glicosamminoglicani
CN113512134B (zh) * 2021-07-30 2022-05-20 梅晔生物医药股份有限公司 一种全分子量分布的透明质酸钠及其制备方法和应用
IT202100027047A1 (it) 2021-10-21 2023-04-21 The Wave Innovation Group Srls Composizione eterogenea a fasi stratificate di acido ialuronico e suo uso intrarticolare

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
CA2060223C (en) † 1991-02-12 1999-07-20 Clarence C. Lee Injectable medical lubricating fluid composition and method of use
US5621093A (en) † 1995-06-06 1997-04-15 Anika Research, Inc. Steam-sterilizing solid hyaluronic acid
US20030104601A1 (en) † 1999-04-01 2003-06-05 Deangelis Paul L. Chondroitin synthase gene and methods of making and using same
US6482401B1 (en) † 1998-12-23 2002-11-19 Naturopathic Laboratories International, Inc. Composition for the relief of joint pain and myofascial pain and method of preparing same
WO2000044367A2 (en) † 1999-02-01 2000-08-03 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
EP1401508A1 (en) * 2001-06-29 2004-03-31 Biovitrum Ab Process for bulk autoclaving
FR2861734B1 (fr) * 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20070141101A1 (en) * 2003-04-10 2007-06-21 The Trustees Of Boston University Method for stimulating angiogenesis and wound healing
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
EP1814518A1 (en) † 2004-11-23 2007-08-08 Alcon Inc. Triple natural polymer viscoelastic composition
US20070010481A1 (en) 2005-07-07 2007-01-11 Matrix Biology Institute Solid State Irradiation of Hyaluronan-Based Solid Preparations, Its Derivatives And Mixtures In An Unsaturated Gaseous Atmosphere And Their Use
CA2621604A1 (en) 2005-09-07 2007-03-15 Amo Regional Holdings Bi-modal hyaluronate solution
EA014469B1 (ru) * 2006-05-11 2010-12-30 Сандра Гоббо Бинарные смеси гиалуроновой кислоты и их терапевтическое применение
ITMI20061030A1 (it) † 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
DE102006060953A1 (de) † 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
EP2581090A1 (en) * 2008-05-13 2013-04-17 Apharm S.r.l. Glycosaminoglycan oral use and compositions
US20100098794A1 (en) * 2008-10-17 2010-04-22 Armand Gerard Topical anti-wrinkle and anti-aging moisturizing cream
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
IT1404145B1 (it) † 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi

Also Published As

Publication number Publication date
FI2614090T4 (fi) 2024-07-24
EP2614090A2 (en) 2013-07-17
EP2614090B1 (en) 2016-11-02
WO2012032151A3 (en) 2012-08-30
LT2614090T (lt) 2017-01-25
DK2614090T3 (da) 2017-01-02
DK2614090T4 (da) 2024-07-15
EP2614090B2 (en) 2024-04-24
ITMI20101635A1 (it) 2012-03-10
IT1402382B1 (it) 2013-09-04
CN103119068A (zh) 2013-05-22
PT2614090T (pt) 2017-02-08
PL2614090T5 (pl) 2024-07-29
US20130165404A1 (en) 2013-06-27
US10266611B2 (en) 2019-04-23
ES2613067T3 (es) 2017-05-22
WO2012032151A2 (en) 2012-03-15
CA2810742C (en) 2018-08-21
CA2810742A1 (en) 2012-03-15
US20160102154A1 (en) 2016-04-14
HUE031242T2 (en) 2017-07-28

Similar Documents

Publication Publication Date Title
LT2614090T (lt) Hibridiniai tarpusavyje susieti hialurono rūgšties kompleksai
PT4033632T (pt) Carregamento de veículo elétrico para veículo elétrico
SI2637710T1 (sl) Formulacije na osnovi hialuronske kisline
PL2400993T3 (pl) Sterylne roztwory kwasu hialuronowego
EP2613954A4 (en) HYBRID SYSTEM
GB2490853B (en) Polyimidazoles for use as bile acid sequestrants
EP2552216A4 (en) 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID DERIVATIVES
EP2543569A4 (en) HYBRID LOCOMOTIVE
EP2606008A4 (en) HYBRID SYSTEM FOR STABILIZATION THROUGH CONTACT AND PRIMARY FLOTATION
ZA201206793B (en) Nucleic acid complexes
EP2580223A4 (en) COMPLEXES OF IMIDAZOLLIGANDS
GB201014374D0 (en) Novel hybrid compounds
TWM389379U (en) Structural improvement of connector
TWM390552U (en) Improved structure of battery connectors
AU5117P (en) Sunsenepiba Senecio hybrid
AU2010295V (en) Sunsenelibubi Senecio hybrid
AU4655P (en) Sunparapibra Mandevilla hybrid
AU4446P (en) WinterSunshine Helleborus hybrid
AU4653P (en) Sunparabeni Mandevilla hybrid
AU4769P (en) VOG051 Mandevilla hybrid
AU4697P (en) GT20 Gazania hybrid
AU5245P (en) Rambovour Anigozanthos hybrid
AU5238P (en) Rambolution Anigozanthos hybrid
AU4409P (en) Inlbusnopr Lobularia hybrid
AU5237P (en) Ramboneer Anigozanthos hybrid